A Comparative Study of Data Mining Algorithms used for Signal Detection in FDA AERS Database
暂无分享,去创建一个
Viswam Subeesh | E. Maheswari | Saraswathy Gr | Ann Mary Swaroop | Satya Sai Minnikanti | Saraswathy Gr | E. Maheswari | Viswam Subeesh | S. S. Minnikanti
[1] N. Shah,et al. Performance of Pharmacovigilance Signal‐Detection Algorithms for the FDA Adverse Event Reporting System , 2013, Clinical pharmacology and therapeutics.
[2] S. Evans,et al. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports , 2001, Pharmacoepidemiology and drug safety.
[3] Marie-Christine Jaulent,et al. Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks , 2015, Drug Safety.
[4] D. Graham,et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase-2 selective and non-selective non-steroidal anti-inflammatory drugs: Nested case-control study , 2005 .
[5] Nicole L. Pratt,et al. Comparing Time to Adverse Drug Reaction Signals in a Spontaneous Reporting Database and a Claims Database: A Case Study of Rofecoxib-Induced Myocardial Infarction and Rosiglitazone-Induced Heart Failure Signals in Australia , 2013, Drug Safety.
[6] R. O’Neill,et al. Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA’s Spontaneous Reports Database , 2002, Drug safety.
[7] K. Verhamme,et al. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project , 2015, PloS one.
[8] M. Lindquist,et al. A Data Mining Approach for Signal Detection and Analysis , 2002, Drug safety.
[9] Daisuke Koide,et al. Comparison of data mining methodologies using Japanese spontaneous reports , 2004, Pharmacoepidemiology and drug safety.
[10] D E Knapp,et al. Discovery of adverse drug reactions. A comparison of selected phase IV studies with spontaneous reporting methods. , 1983, JAMA.
[11] M. Lindquist,et al. A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database , 2000, Drug safety.
[12] A. Freedman,et al. Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database , 2012, Drug Safety.
[13] M. Lindquist,et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions , 2002, Pharmacoepidemiology and drug safety.
[14] Gaurav Deshpande,et al. Data Mining in Drug Safety , 2010, Pharmaceutical Medicine.
[15] Manfred Hauben,et al. Potential Utility of Data‐Mining Algorithms for Early Detection of Potentially Fatal/Disabling Adverse Drug Reactions: A Retrospective Evaluation , 2005, Journal of clinical pharmacology.
[16] A. Bate,et al. Quantitative signal detection using spontaneous ADR reporting , 2009, Pharmacoepidemiology and drug safety.
[17] Antoine Egberts,et al. The reporting odds ratio versus the proportional reporting ratio: ‘deuce’ , 2004, Pharmacoepidemiology and Drug Safety.
[18] H. Tilson,et al. No evident association between efavirenz use and suicidality was identified from a disproportionality analysis using the FAERS database , 2014, Journal of the International AIDS Society.
[19] B. Chakraborty. Pharmacovigilance: A data mining approach to signal detection , 2015, Indian journal of pharmacology.
[20] Kenneth J Rothman,et al. The reporting odds ratio and its advantages over the proportional reporting ratio , 2004, Pharmacoepidemiology and drug safety.